RA Capital Management’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

RA Capital Management’s Portfolio WGBS Stock Details WGBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-41,080	Closed	-$279K	–	53
2015 Q3	$279K	Hold	41,080	–	–	0.04%	46
2015 Q2	$647K	Sell	41,080 -10,000	-20%	-$205K	0.07%	57
2015 Q1	$1.16M	Sell	51,080 -60,920	-54%	-$1.21M	0.11%	49
2014 Q4	$1.68M	Hold	112,000	–	–	0.18%	37
2014 Q3	$2.44M	Buy	+112,000	New	+$2.5M	0.29%	28

Other funds holding WGBS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RA Capital Management's WGBS Position: Q4 2015 in Review

RA Capital Management sold out of WaferGen Bio-systems, Inc. (WGBS) in Q4 2015, closing a stake of 41,080 shares — an estimated $279K sold.

RA Capital Management first reported a position in WGBS in Q3 2014 and held it in 5 quarters. The position peaked at $2.44M in Q3 2014. 16 funds tracked by Wall St. Rank hold WGBS as of Q4 2015.

RA Capital Management reported no remaining WaferGen Bio-systems, Inc. position as of Q4 2015 after selling out during the quarter.
RA Capital Management sold 41,080 WaferGen Bio-systems, Inc. shares in Q4 2015, an estimated $279K.
RA Capital Management first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 5 quarters.
RA Capital Management's WaferGen Bio-systems, Inc. position peaked at $2.44M in Q3 2014.
16 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q4 2015.

Based on RA Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.